Ablation Technologies Market By Application (Cardiovascular Disease Treatment, Cancer Treatment, Pain Management, Urological Treatment, Gynecological Treatment, Orthopedic Treatment, Cosmetic/ Aesthetic Treatment), By Products (Radio Frequency Ablators, Laser Ablators, Ultrasound Ablators, Electrical Ablators, Microwave Ablators, Cryoablation Ablators, Hydrothermal Ablators), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jun 13, 2016

Key Findings


The global ablation technologies market is anticipated to grow at a CAGR of 11.31% for the forecast period 2015-2022. Ablation is the removal of material from the surface of an object by chipping, vaporization or other erosive processes. The major factors driving the global ablation technologies market are growing prevalence of cardiovascular diseases and increasing incidences of cancer. According to WHO, approximately 17 million deaths occur each year due to CVD diseases, in which atrial defibrillation is the most major disorder. Moreover, the incidence of atrial fibrillation increases with the age and globally almost 1 out of 20 people ageing 65 and above is suffering from it. Also, according to the data collected by Lymphoma and Leukemia Society (LLS), around 171,550 people of US were diagnosed with blood related disorders and cancers like myeloma, leukemia and lymphoma. This is one of the important causes of such a huge market share and reason for the growth of global ablation technologies market in U.S. In addition to it, increased number of hospitals, ablation and surgical centers, rising number of training programs, increasing patient base in emerging economies and increased investment for development of ablation devices improving reimbursement scenario in established markets, growing prevalence of cardiovascular disease and growing adoption of minimally invasive procedures are few factors which are accelerating the growth of global ablation technologies market. However, reuse and reprocessing of devices in developing countries, stringent government regulations and increased healthcare cost and containment measures are major restraints hampering the market potential of global ablation technologies market. Also increasing trends of bulk purchasing by few organization is intensifying pricing pressure on various market players.


Market Segment Insight


The global ablation technologies market is segmented on the basis of application and products. On the basis of application, the market is segmented as cardiovascular disease treatment, cancer treatment, pain management, urological treatment, orthopedic treatment, cosmetic/ aesthetic treatment, gynecological treatment and others. In the application segment, cardiovascular and cancer treatment is the largest market. Application segment is expected to grow at highest CAGR during the forecast period. The large market share of the cardiovascular diseases treatment segment is attributed to the rising incidences of AF across the globe, development of novel ablation technologies for the diagnosis of AF and increasing market reach of cardiac ablation catheters worldwide. On the basis of products, the market is segmented as cryoablation ablators, hydrothermal ablators, radio frequency ablation, laser ablation, ultrasound ablation, electrical ablation and microwave ablation. Radio frequency ablation is the leader in product type segment owing to its high efficacy, safety, and less time duration for the treatment of AF, cancer, and pain management than others. However, the microwave ablators segment is anticipated to have highest CAGR in the forecast period. This is due to its high success rate in cancer treatments, and various additional advantages like large ablation zone and resistance from heat sink effects.


Regional Insight


The major regional segments analyzed in the report include North America, Europe, Asia Pacific, and Rest of the World with further bifurcation of them on country level, which includes U.S, Canada, India, China, Japan, Germany, U.K., Spain, Brazil etc. North America is the leader in global ablation technology market followed by Europe. This is due to factors like technological advancement in ablation technology field, better healthcare infrastructure in comparison to any other region, high disposal income of individual and increase in lifestyle related diseases in this region. However, Asia Pacific is the fastest growing market and is anticipated to grow at the highest CAGR in the forecast period. Increasing popularity of minimally invasive surgeries in the region, government support to increase population access for elective surgeries, increasing investment by global players in the region, huge patient base and improving healthcare infrastructure are various factors stimulating the growth of the ablation technologies market in the APAC region.


Competitive Insights


Ablation technologies are an attractive market for new entrants because of high returns on investment on ablation products and high significant growth potential. Some of the key market players are Angiodynamics, Inc. , Atricure, Inc. , Biosense Webster, Inc. , Boston Scientific Corporation, CathRx Ltd, Conmed Corporation , Endosense SA, Galil Medical Inc., Japan Lifeline Co., Ltd., Medtronic PLC , Olympus Corporation , Osypka AG, Smith & Nephew, St. Jude Medical, Inc. and TZ Medical, Inc. . Expansions, mergers & acquisition and collaborations are the key strategies adopted by the market players to sustain in the market and increase their product portfolio. In April 2016, Atricure, Inc. after getting 510(k) clearance has introduced cryoFORM Cryoablation Probe in the US market. The product depicts company’s core strengths in Cryoablation technology and has features like thermal capacity to remove heat and active defrost due to which customer get increased probe flexibility, necessary for minimally invasive cardiac surgeries.

CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12


CHAP 2. EXECUTIVE SUMMARY 13
2.1. GLOBAL ABLATION TECHNOLOGIES MARKET SUMMARY & KEY BUYING CRITERIA 13
2.2. GLOBAL ABLATION TECHNOLOGIES MARKET OUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. GLOBAL ABLATION TECHNOLOGIES MARKET VALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13


CHAP 3. GLOBAL ABLATION TECHNOLOGIES MARKET 14
3.1. MARKET DRIVER ANALYSIS 14
3.1.1. RISING INCIDENCE OF CANCER 14
3.1.2. INCREASING NUMBER OF HOSPITAL, ABLATION AND SURGICAL CENTERS 14
3.1.3. GROWING PREVALENCE OF CARDIOVASCULAR DISEASES 14
3.1.4. GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES 14
3.1.5. IMPROVING REIMBURSEMENT SCENARIO IN ESTABLISHED MARKETS 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.2.1. REUSE AND REPROCESSING OF DEVICES IN DEVELOPING COUNTRIES 14
3.2.2. HEALTHCARE COST AND CONTAINMENT MEASURES 14
3.3. KEY OPPORTUNITIES 14
3.3.1. RISING NUMBER OF TRAINING PROGRAMS 14
3.3.2. EMERGING MARKETS 14
3.3.3. INCREASING FUNDING FOR THE DEVELOPMENT OF NOVEL ABLATION DEVICES 14
3.4. CHALLENGES 14
3.4.1. THERAPEUTIC CHALLENGE 14
3.4.2. STRINGENT REGULATORY GUIDELINES 14


CHAP 4. INDUSTRY ANALYSIS 15
4.1. GLOBAL ABLATION TECHNOLOGIES MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. GLOBAL ABLATION TECHNOLOGIES MARKET– PESTEL ANALYSIS 15
4.3. GLOBAL ABLATION TECHNOLOGIES MARKET– GAP ANALYSIS 15


CHAP 5. GLOBAL ABLATION TECHNOLOGIES MARKET BY APPLICATION 2012-2022 ($ MILLION) 16
5.1. GLOBAL ABLATION TECHNOLOGIES MARKET BY CARDIOVASCULAR DISEASE TREATMENT 2012-2022 ($ MILLION) 16
5.2. GLOBAL ABLATION TECHNOLOGIES MARKET BY CANCER TREATMENT 2012-2022 ($ MILLION) 16
5.3. GLOBAL ABLATION TECHNOLOGIES MARKET BY PAIN MANAGEMENT 2012-2022 ($ MILLION) 16
5.4. GLOBAL ABLATION TECHNOLOGIES MARKET BY UROLOGICAL TREATMENT 2012-2022 ($ MILLION) 16
5.5. GLOBAL ABLATION TECHNOLOGIES MARKET BY GYNECOLOGICAL TREATMENT 2012-2022 ($ MILLION) 16
5.6. GLOBAL ABLATION TECHNOLOGIES MARKET BY ORTHOPEDIC TREATMENT 2012-2022 ($ MILLION) 16
5.7. GLOBAL ABLATION TECHNOLOGIES MARKET BY COSMETIC/ AESTHETIC TREATMENT 2012-2022 ($ MILLION) 16
5.8. GLOBAL ABLATION TECHNOLOGIES MARKET BY OTHERS TREATMENT 2012-2022 ($ MILLION) 16


CHAP 6. GLOBAL ABLATION TECHNOLOGIES MARKET BY PRODUCTS 2012-2022 ($ MILLION) 17
6.1. GLOBAL ABLATION TECHNOLOGIES MARKET BY RADIO FREQUENCY ABLATORS 2012-2022 ($ MILLION) 17
6.2. GLOBAL ABLATION TECHNOLOGIES MARKET BY LASER ABLATORS 2012-2022 ($ MILLION) 17
6.3. GLOBAL ABLATION TECHNOLOGIES MARKET BY ULTRASOUND ABLATORS 2012-2022 ($ MILLION) 17
6.4. GLOBAL ABLATION TECHNOLOGIES MARKET BY ELECTRICAL ABLATORS 2012-2022 ($ MILLION) 17
6.5. GLOBAL ABLATION TECHNOLOGIES MARKET BY MICROWAVE ABLATORS 2012-2022 ($ MILLION) 17
6.6. GLOBAL ABLATION TECHNOLOGIES MARKET BY CRYOABLATION ABLATORS 2012-2022 ($ MILLION) 17
6.7. GLOBAL ABLATION TECHNOLOGIES MARKET BY HYDROTHERMAL ABLATORS 2012-2022 ($ MILLION) 17


CHAP 7. GLOBAL ABLATION TECHNOLOGIES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 18
7.1. GLOBAL ABLATION TECHNOLOGIES MARKET BY REGION 2012-2022 ($ MILLION) 18
7.2. NORTH AMERICA 18
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 18
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.2.3.1. U.S. 18
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.2.3.2. CANADA 18
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.3. EUROPE 19
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3.3.1. GERMANY 19
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3.3.2. UK 19
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3.3.3. FRANCE 19
7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3.3.4. REST OF EUROPE 19
7.3.3.4.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($ MILLION) 20
7.3.3.4.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($ MILLION) 20
7.4. ASIA PACIFIC 20
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.4.3.1. CHINA 20
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.4.3.2. INDIA 20
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.4.3.3. JAPAN 20
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 20
7.4.3.4. SOUTH KOREA 20
7.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 20
7.4.3.5. REST OF APAC 21
7.4.3.5.1. REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.3.5.2. REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.5. REST OF THE WORLD 21
7.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
7.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.5.3.1. LATIN AMERICA 21
7.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.5.3.2. MIDDLE EAST AND AFRICA 21
7.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21


CHAP 8. COMPETITIVE LANDSCAPE 22
8.1. ANGIODYNAMICS, INC. 23
8.1.1. COMPANY OVERVIEW 23
8.1.2. SCOT ANALYSIS 23
8.1.3. PRODUCT BENCHMARKING 23
8.1.4. STRATEGIC INITIATIVES 23
8.2. ATRICURE, INC. 23
8.2.1. COMPANY OVERVIEW 23
8.2.2. SCOT ANALYSIS 23
8.2.3. PRODUCT BENCHMARKING 23
8.2.4. STRATEGIC INITIATIVES 23
8.3. BIOSENSE WEBSTER, INC. 23
8.3.1. COMPANY OVERVIEW 23
8.3.2. SCOT ANALYSIS 23
8.3.3. PRODUCT BENCHMARKING 23
8.3.4. STRATEGIC INITIATIVES 23
8.4. BOSTON SCIENTIFIC CORPORATION 23
8.4.1. COMPANY OVERVIEW 23
8.4.2. SCOT ANALYSIS 23
8.4.3. PRODUCT BENCHMARKING 23
8.4.4. STRATEGIC INITIATIVES 23
8.5. CATHRX LTD 23
8.5.1. COMPANY OVERVIEW 23
8.5.2. SCOT ANALYSIS 23
8.5.3. PRODUCT BENCHMARKING 23
8.5.4. STRATEGIC INITIATIVES 23
8.6. CONMED CORPORATION 23
8.6.1. COMPANY OVERVIEW 23
8.6.2. SCOT ANALYSIS 24
8.6.3. PRODUCT BENCHMARKING 24
8.6.4. STRATEGIC INITIATIVES 24
8.7. ENDOSENSE SA 24
8.7.1. COMPANY OVERVIEW 24
8.7.2. SCOT ANALYSIS 24
8.7.3. PRODUCT BENCHMARKING 24
8.7.4. STRATEGIC INITIATIVES 24
8.8. GALIL MEDICAL INC. 24
8.8.1. COMPANY OVERVIEW 24
8.8.2. SCOT ANALYSIS 24
8.8.3. PRODUCT BENCHMARKING 24
8.8.4. STRATEGIC INITIATIVES 24
8.9. JAPAN LIFELINE CO., LTD. 24
8.9.1. COMPANY OVERVIEW 24
8.9.2. SCOT ANALYSIS 24
8.9.3. PRODUCT BENCHMARKING 24
8.9.4. STRATEGIC INITIATIVES 24
8.10. MEDTRONIC PLC 24
8.10.1. COMPANY OVERVIEW 24
8.10.2. SCOT ANALYSIS 24
8.10.3. PRODUCT BENCHMARKING 24
8.10.4. STRATEGIC INITIATIVES 24
8.11. OLYMPUS CORPORATION 24
8.11.1. COMPANY OVERVIEW 24
8.11.2. SCOT ANALYSIS 24
8.11.3. PRODUCT BENCHMARKING 24
8.11.4. STRATEGIC INITIATIVES 24
8.12. OSYPKA AG 25
8.12.1. COMPANY OVERVIEW 25
8.12.2. SCOT ANALYSIS 25
8.12.3. PRODUCT BENCHMARKING 25
8.12.4. STRATEGIC INITIATIVES 25
8.13. SMITH & NEPHEW 25
8.13.1. COMPANY OVERVIEW 25
8.13.2. SCOT ANALYSIS 25
8.13.3. PRODUCT BENCHMARKING 25
8.13.4. STRATEGIC INITIATIVES 25
8.14. ST. JUDE MEDICAL, INC. 25
8.14.1. COMPANY OVERVIEW 25
8.14.2. SCOT ANALYSIS 25
8.14.3. PRODUCT BENCHMARKING 25
8.14.4. STRATEGIC INITIATIVES 25
8.15. TZ MEDICAL, INC. 25
8.15.1. COMPANY OVERVIEW 25
8.15.2. SCOT ANALYSIS 25
8.15.3. PRODUCT BENCHMARKING 25
8.15.4. STRATEGIC INITIATIVES 25

TABLE 1 GLOBAL ABLATION TECHNOLOGIES MARKET BY APPLICATION 2012-2022 ($ MILLION) 25
TABLE 2 GLOBAL ABLATION TECHNOLOGIES MARKET BY CARDIOVASCULAR DISEASE TREATMENT 2012-2022 ($ MILLION) 25
TABLE 3 GLOBAL ABLATION TECHNOLOGIES MARKET BY CANCER TREATMENT 2012-2022 ($ MILLION) 25
TABLE 4 GLOBAL ABLATION TECHNOLOGIES MARKET BY PAIN MANAGEMENT 2012-2022 ($ MILLION) 26
TABLE 5 GLOBAL ABLATION TECHNOLOGIES MARKET BY UROLOGICAL TREATMENT 2012-2022 ($ MILLION) 26
TABLE 6 GLOBAL ABLATION TECHNOLOGIES MARKET BY GYNECOLOGICAL TREATMENT 2012-2022 ($ MILLION) 26
TABLE 7 GLOBAL ABLATION TECHNOLOGIES MARKET BY ORTHOPEDIC TREATMENT 2012-2022 ($ MILLION) 26
TABLE 8 GLOBAL ABLATION TECHNOLOGIES MARKET BY COSMETIC/ AESTHETIC TREATMENT 2012-2022 ($ MILLION) 26
TABLE 9 GLOBAL ABLATION TECHNOLOGIES MARKET BY OTHERS TREATMENT 2012-2022 ($ MILLION) 26
TABLE 10 GLOBAL ABLATION TECHNOLOGIES MARKET BY PRODUCTS 2012-2022 ($ MILLION) 26
TABLE 11 GLOBAL ABLATION TECHNOLOGIES MARKET BY RADIO FREQUENCY ABLATORS 2012-2022 ($ MILLION) 26
TABLE 12 GLOBAL ABLATION TECHNOLOGIES MARKET BY LASER ABLATORS 2012-2022 ($ MILLION) 26
TABLE 13 GLOBAL ABLATION TECHNOLOGIES MARKET BY ULTRASOUND ABLATORS 2012-2022 ($ MILLION) 26
TABLE 14 GLOBAL ABLATION TECHNOLOGIES MARKET BY ELECTRICAL ABLATORS 2012-2022 ($ MILLION) 26
TABLE 15 GLOBAL ABLATION TECHNOLOGIES MARKET BY MICROWAVE ABLATORS 2012-2022 ($ MILLION) 26
TABLE 16 GLOBAL ABLATION TECHNOLOGIES MARKET BY CRYOABLATION ABLATORS 2012-2022 ($ MILLION) 26
TABLE 17 GLOBAL ABLATION TECHNOLOGIES MARKET BY HYDROTHERMAL ABLATORS 2012-2022 ($ MILLION) 26
TABLE 18 GLOBAL ABLATION TECHNOLOGIES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 26
TABLE 19 GLOBAL ABLATION TECHNOLOGIES MARKET BY REGION 2012-2022 ($ MILLION) 26
TABLE 20 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 21 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 27
TABLE 22 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 23 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 24 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 25 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 26 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 27 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 28 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 27
TABLE 29 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 30 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 31 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 32 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 33 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 34 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 35 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 36 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 27
TABLE 37 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 27
TABLE 38 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 39 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 28
TABLE 40 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 41 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 42 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 43 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 44 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 45 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 46 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 47 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 48 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 49 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 50 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 51 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 52 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 28
TABLE 53 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 54 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 55 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 56 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 57 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29

FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 8 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($ MILLION) 29
FIGURE 9 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 10 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 11 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 12 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 13 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 14 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 15 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 16 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 17 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)